Status:
RECRUITING
Psychological Impact of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation on Donors
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Haplo-identical Transplantation
Transplantation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Allogeneic hematopoietic stem cell transplantation (allo-HSC) is currently one of the only curative treatments for haematological malignancies with a poor prognosis, the realization of which presuppos...
Detailed Description
This is a prospective, exploratory and bicentric study with a quantitative and qualitative approach, with the aim of exploring the psychosocial aspects of the experience of haplo-identical transplanta...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Identical haplo CSH donors ascending (parents) or descending (children)
- Major identical haplo HSC donors
- Haplo-identical HSC donors living in mainland France and cared for in the centers participating in the study
- Haplo-identical HSC donors benefiting from Social Security System.
- Haplo-identical HSC donors who have signed the consent form
- \- Ability to read and write in French
- Exclusion Criteria:
- \- Insufficient understanding of the French language
Exclusion
Key Trial Info
Start Date :
January 22 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06089850
Start Date
January 22 2024
End Date
January 1 2028
Last Update
April 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service D'hématologie Clinique et thérapie cellulaire - Hôpital St Antoine
Paris, France